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ABSTRACT
Clinical trials predicate subject eligibility on a diversity of criteria
ranging from patient demographics to food allergies. Trials post
their requirements as semantically complex, unstructured free-text.
Formalizing trial criteria to a computer-interpretable syntax would
facilitate eligibility determination. In this paper, we investigate an
information extraction (IE) approach for grounding criteria from
trials in ClinicalTrials.gov to a shared knowledge base. We frame
the problem as a novel knowledge base population task, and im-
plement a solution combining machine learning and context free
grammar. To our knowledge, this work is the first criteria extraction
system to apply attention-based conditional random field architec-
ture for named entity recognition (NER), and word2vec embedding
clustering for named entity linking (NEL). We release the resources
and core components of our system on GitHub.1 Finally, we report
our per module and end to end performances; we conclude that our
system is competitive with Criteria2Query, which we view as the
current state-of-the-art in criteria extraction [20].
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1 INTRODUCTION
Clinical trials are vital for understanding diseases and testing new
treatments. However trials in the United States today face signifi-
cant challenges recruiting enough participants [4][8] and establish-
ing representative diversity in their study populations [10], which
regularly leads to difficulty completing trials and generalizing out-
comes across populations.
ClinicalTrials.gov is a centralized public database of 330,000+
clinical studies maintained by the National Library of Medicine
(NLM) [21]. In addition to hosting every American and many inter-
national trials, ClinicalTrials.gov also provides filters for a handful
of important eligibility criteria such as patient age, gender, trial
location, and study condition. Researchers have the option to spec-
ify additional, more specific, eligibility criteria such as treatment
1https://github.com/facebookresearch/Clinical-Trial-Parser
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history and pre-existing conditions. These criteria are written in
free-text descriptions, the majority of which include semantically
complex language and can require expert domain knowledge to
understand [15]. With 32,000+ new trials added annually to Clini-
calTrials.gov, automated criteria extraction is a necessary requisite
for sophisticated trial discovery and cohort identification platforms.
Previous work on automated criteria extraction take many ap-
proaches [1][17]. Systems such as EliXR [18], EliXR-TIME [2], and
ERGO [16] build on pattern matching and rules. Other researchers
such as Butler et al. [3] and Luo et al. [12] create text mining algo-
rithms to identify common criteria across trials. There have also
been significant research focusing on information extraction in-
cluding Bruijn et al.’s work [6], EliIE [9], and Criteria2Query [20].
In this work, we develop an information extraction approach for
eligibility criteria extraction which combines machine learning and
context free grammar. Our work makes the following contributions:
• We formulate eligibility criteria extraction as a novel knowl-
edge base population task. Working from this theoretical
framework, we achieve an end to end accuracy of 0.753.
• To our knowledge, this is the first attention-based NER im-
plementation among criteria extraction systems. Our NER
detects 10 fine-grained entity classes with precision 0.911
and recall 0.716.
• To our knowledge, this is the first NEL implementation to
leverage embedding clustering among criteria extraction
systems. Our NEL achieves an accuracy of 0.485.
• We open sourced a library of our code and data.1 The library
is not the end to end system described in this paper; rather
it is the collection of foundational resources from which
our system is derived. The release includes our context-
free grammar (CFG) code, NER model binary, embeddings,
and the largest, most diverse data-set of clinical trial enti-
ties/attributes of which we are aware.
2 DATA-SET DESCRIPTION
We present a new data-set of 121,221 clinical trial entities, attributes,
and limits. It is double-annotated from a random sample of 3,314
clinical studies across all disease and treatment areas from Clinical-
Trials.gov. As far as we are aware, this data-set represents the largest
of its kind. Here, we define entities as non-parametric patient prop-
erties, attributes as numerical/ordinal properties, and limits as con-
straints on attributes. The data-set distribution is shown in Table 1.
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Figure 1: System architecture.
Class Count Examples
Entity Treatment 31K surgery, remdesivir
Chronic disease 26K kidney failure, AD
Cancer 9.3K leukemia
Gender 3.7K —
Pregnancy 2.8K —
Allergy 1.9K allergy to aspirin
Contraception consent 1.6K —
Language literacy 482 —
Technology access 132 email, cellphone
Ethnicity 82 —
Attribute Clinical variable 13K ECOG, Hgb count
Age 2.6K —
Body mass index 289 —
Limit Upper bound 14K < 25 kд/m2
Lower bound 14K ≥ 18 years
Table 1: Distribution of entity, attribute, and limit classes.
3 METHOD
We divide criteria extraction into two modules: (1) a classic IE
pipeline to extract entity criteria and (2) a CFG engine to extract
attribute criteria; see Figure 1.
3.0.1 Criteria Definition. Given a trial T in ClinicalTrials.org, its
criteria text can be split into inclusion criteria blocks (ICT ) and
exclusion criteria blocks (ECT ). ICT consists of inclusion criteria
(i ∈ ICT ) all of which a participant must satisfy in order to be
eligible for T . ECT consists of exclusion criteria (e ∈ ECT ) all of
which a participant must not satisfy in order to be eligible forT . For
the purpose of this paper it is assumed all criteria (c ∈ ICT ∪ ECT )
are logically simple. Here a logically simple criterion is defined
as a constraint on a single entity or attribute. We formalize the
trial-level eligibility for T (AT ) as:
AT = ICT∧!ECT =
( M⋂
x=1
ix
)
∧!
( N⋃
x=M+1
ex
)
=
N⋂
x=1
f (x)
f (x) =
{
ix , 1 ≤ x ≤ M
!ex , M < x ≤ N
(1)
3.0.2 Task Definition. Extraction of criteria is framed as a classic
knowledge base population task. Given unstructured text, the goal
is to extract Resource Description Framework (RDF) facts repre-
senting individual criterion (c ∈ ICT ∪ ECT ) in the form:
(concept , constraint , trial)
concept is some entity (e.g. ’leukemia’) or attribute (e.g. ’BMI’)
within the knowledge base. trial is the unique NCT identifier of
a trial T in ClinicalTrials.gov (e.g. ’NCT00097734’). constraint is
the eligibility requirement T places upon concept . Example RDF
triplets: (’NCT00097734’, ’excludes participants with’, ’leukemia’),
(‘NCT03051984‘, ’requires participants have ≤ 38kд/m2’, ’BMI’).
3.1 Knowledge Base
We leverage Medical Subject Headings (MeSH) as our primary
knowledge source. MeSH is an NLM controlled vocabulary origi-
nally designed as a taxonomy for biomedical research literature. It
was chosen for its simplicity and versatility relative to other com-
mon knowledge bases such as the International Classification of
Diseases (ICD-9/10) and Systematized Nomenclature of Medicine
– Clinical Terms (SNOMED-CT). According to Yao et al.’s analy-
sis, though MeSH (27,000 concepts) is much smaller than ICD-9
(70,000 concepts) and SNOMED-CT (350,000 concepts), it captures
the most important disease concepts significantly better relative to
both ICD-9 and SNOMED-CT [19].
We use MeSH concepts for our treatment and disease classes. We
supplement 66 curated concepts for the remaining entity classes
(pregnancy, contraception consent, etc), and 71 curated attributes
(age, BMI, ECOG, platelet count, etc). Our curated entities and
attributes are available on GitHub.1 Entities and attributes are or-
ganized in a hierarchical structure from general to specific, and
seamlessly combine to create one cohesive knowledge base.
3.2 Pre-Processing
Trial eligibility is segmented into inclusion and exclusion blocks
using rules operating on headings. The text is delexicalized to mask
digits and punctuation, normalized for case, and tokenized. Ev-
ery line of text is then individually considered by the IE and CFG
modules.
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Att-BiLSTM-CRF
Hyper − param. Value
batch size 64
clipping τ = 1
dropout [0.2, 0.2]
char_embed dim 100
BiLSTM layer 1
LSTM dim 128
attn dim 64
mlp decoder dim 256
Word2vec
Hyper − param. Value
model cbow
loss ns
dim 100
window size 5
epsilon ϵ = 1.0−6
learning rate 0.05
Table 2: Hyper-parameter configurations.
3.3 Entity Criteria Extraction
3.3.1 Named Entity Recognition (NER). The goal of NER is to ex-
tract all entity mentions from unstructured text and categorize
mentions by entity class. We trained an attention-based bidirec-
tional Long Short-Term Memory model with a conditional random
field layer (Att-BiLSTM-CRF) in PyText [14] for entity recognition
of all 10 entity classes. Our model hyper-parameters can be seen in
Table 2. Att-BiLSTM-CRF architecture has been shown as state-of-
the-art for the task of chemical and disease NER by Luo et al. [11]
and Zhai et al. [22].
3.3.2 Named Entity Linking (NEL). The goal of NEL is to link entity
mentions with concepts in our knowledge base. We split the task
into clustering and grounding. A word2vec model is trained with
FastText [13] on the trial descriptions and eligibility criteria of all
300K+ trials present in ClinicalTrials.gov as of May 2019. Our model
hyper-parameters can be seen in Table 2. All extracted entity men-
tions are projected into the embedding space and clustered with DB-
SCAN. Clusters are then grounded to entities and their synonyms
in the knowledge base according to Sørensen-Dice similarity [7].
3.3.3 Relationship Extraction (RE). The goal of RE is to identify
requirements trials place upon concepts given an unstructured text
source. For amenability, we reduce the RE task to a simple binary
classification of negation detection: Given a trial T and some ex-
tracted entity e (e.g. "leukemia"),T must either accept subjects with
e or reject subjects with e . This definition of the task does not dis-
tinguish temporal requirements: whether T accepts subjects who
previously had e or subjects who currently have e is not differenti-
ated.
Medical negation detection is a known problem and solutions
usually center around regular expression algorithms [5]. Our nega-
tion detection algorithm first searches for specific negation key-
words per entity class. Then extracts negation according to string
distance between keyword and entity mention.
3.4 Attribute Criteria Extraction
We rely on a context free grammar (CFG) engine to recognize,
ground, and predict criteria for attributes in the knowledge base. A
custom lexer divides and categorizes criteria into tokens (attribute,
unit, comparison, number, negation, end-of-string, unknown, etc).
A modified Cocke-Younger-Kasami (CYK) algorithm builds parse
trees from the tokens. The interpreter analyzes the parse trees
removing duplicates and sub-trees. The remaining trees are then
evaluated into RDF triplets.
3.5 Aggregation
Following Equation 1, exclusion criteria are cast to inclusion criteria
by negation. To negate RDF facts, the constraint is simply inverted
(e.g. "can-have" becomes "cannot-have", ">" becomes "≤"). Inclusion
criteria are left unchanged. After casting, all entity and attribute
criteria are intersected to calculate trial-level eligibility of T (AT ).
Some trials include redundant criteria for clarity; such criteria
are de-duplicated during aggregation. Contradicting criteria, which
are either the result of an error in our system or a semantic er-
ror in the raw criteria text, are also removed. General criteria are
dropped in the presence of more specific criteria according to en-
tity and attribute hierarchy; for example (’NCT00594516’, ’excludes
participants with’, ’hepatitis’) is dropped because (’NCT00594516’,
’excludes participants with’, ’hepatitis b’) is also extracted. As a final
step, we employ a semantic check at the trial level to filter illogical
constraint sets. For example no trial should require participants to
both be pregnant and on birth control.
4 RESULTS & DISCUSSION
Table 3 shows the performance of our system as evaluated on the
10 trial golden set created by Yuan et al. for Criteria2Query [20].
We release the evaluations from our internal build.1
4.0.1 Entity Recognition. Our NER model employs an Att-BiLSTM-
CRF architecture trained with data from 3,314 randomly sampled
trials. It predicts 10 fine-grained entity classes shown in Table 1
at 0.802 F1 score. Criteria2Query’s NER model employs a classic
CRF architecture trained with data from 230 AlzheimerâĂŹs dis-
ease trials. It predicts 5 general entity classes (Condition, Drug,
Measurement, Procedure, Observation) at 0.804 F1 score [20]. Our
NER model extracts more fine-grained entities while maintaining a
competitive F1 score. The Att-BiLSTM-CRF architecture has been
successfully applied for many medical applications [11][22]. To
our knowledge, this work is the first to apply Att-BiLSTM-CRF,
or any other attention-based architecture, to clinical trial criteria
extraction.
4.0.2 Entity Linking. Our NEL accuracy of 0.485 (82/169) slightly
outperforms the 0.447 (51/114) accuracy of Criteria2Query’s NEL
module. Criteria2Query was intended as a companion tool for trial
investigators. For NEL, it relies on predefined concept sets aug-
mented by a sophisticated interface for creating new custom con-
cept sets [20]. Our NEL took a fundamentally different approach.
We trained a word2vec model from trial descriptions which we then
used to project, cluster, and ground entity embeddings to our knowl-
edge base. In this way our NEL construction was self-supervised,
and can be easily configured to ground any knowledge base.
From an absolute perspective, NEL is the bottleneck of our
pipeline. It fails to ground 0.416 (64/154) of valid extractions. Of
incorrect groundings, 0.696 (16/23) are from over generalization
(e.g. "left main stem stenosis" is incorrectly grounded to "stenosis").
We believe these limitations are the consequence of our knowledge
base, composed primarily of MeSH concepts. MeSH is comprised
of orders of magnitude fewer and more general concepts relative to
other standards such as SNOMED-CT and ICD-9/10 [19]. In the task
of trial criteria extraction, requirements can be exceedingly specific
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Our System Criteria2Query
Precision Recall F1 Precision Recall F1
Entity Recognition 0.911 (154/169)[0.864-0.953]
0.716 (154/215)
[0.656-0.772]
0.802
[0.754-0.837]
0.902 (156/173)
[0.844-0.936]
0.726 (156/215)
[0.661-0.777]
0.804
[0.760-0.841]
Accuracy Accuracy
Entity Linking 0.485 (82/169) [0.408-0.556] 0.447 (51/114) [0.351-0.535]
Attribute Linking 0.750 (15/20) [0.450-0.850]⋆ 0.800 (16/20) [0.500-0.900]
Relationship Extraction 0.838 (57/68) [0.750-0.926] -
End to End Performance 0.753 (64/85) [0.661-0.844] -
Table 3: Evaluation on Criteria2Query’s golden set with 95% confidence interval.
⋆Evaluation of this metric is inferred; refer to section 4.0.3 for more detail.
[15]. To accurately link entities requires a comprehensive knowl-
edge base of equivalently specific concepts. We leave experimenta-
tion with specialized and expanded knowledge bases (e.g. curated
breast cancer trial requirements, SNOMED-CT) for future work.
4.0.3 Attribute Linking. Attribute recognition, linking and con-
straint extraction are performed in tandem by our CFG engine.
Evaluated on the golden set, the end to end precision of our at-
tribute criteria extraction is 0.938 (15/16). Criteria2Query similarly
relies upon rules for attribute extraction, but does not report its end
to end accuracy, only its linking accuracy of 0.800 (16/20) [20]. For
the purpose of comparison, we infer the attribute linking accuracy
of our CFG engine to be 0.750 (15/20).
4.0.4 Relationship Extraction. We achieve an accuracy of 0.838
(57/68) for our rule-based negation detection module. There is no
counterpart to our RE module in Criteria2Query. Criteria2Query
frames its RE task to infer relations between entities and attributes,
rather than concepts and trials.
The expressiveness of our framework is constrained by the sim-
plification of RE to just binary negation detection, and our assump-
tion that all criteria are logically simple. Collectively, 0.636 (7/11) of
RE errors could be avoided by expanding the relation ontology to
capture a wider array of requirements (e.g. history of disease), and
handling logically complex criteria (e.g. conditional and compound
constraints).
4.0.5 End to End Performance. Our end to end accuracy on Crite-
ria2Query’s golden set is 0.753 (64/85) as evaluated by a medical
professional. Criteria2Query does not report its end to end accuracy
for comparison. However, EliIE, the precursor to Criteria2Query,
does report its end to end accuracy of 0.71 [9].
5 CONCLUSION
We present a novel formulation of clinical trial eligibility criteria
extraction as a knowledge base population task. As far as we are
aware, this work is the first to apply attention-based architecture to
clinical trial entity extraction, and word2vec embedding clustering
to clinical trial entity linking. We open source a library containing
our training data, CFG, embeddings, and NER model binary. We
evaluate our system against Yuan et al.’s Criteria2Query pipeline
[20], which we consider the state-of-the-art, to demonstrate the
competitiveness of our system.
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